The GAO has issued a report entitled  “Nonprescription Drugs: Considerations Regarding a Behind-the-Counter Drug Class.” This report examines the pros and cons of establishing an additional class of nonprescription drugs that would be held behind the counter (BTC) but would require the intervention of a pharmacist before being dispensed, and issues that must be addressed before establishing such a drug class.